Home › Companies › Akebia Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Akebia Therapeutics, Inc.’s Form 8-K, filed June 22, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 17, 2026: 7 items on Akebia Therapeutics, Inc.’s Form 8-K, filed June 22, 2026: 2 approved · 5 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Akebia Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Akebia Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 22, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Adrian Adams | 102,040,314 | -- | -- | 41,312,586 | 48,297,931 | 71% | Not verified | — |
| Elect Director: Michael Rogers | 102,377,117 | -- | -- | 40,975,783 | 48,297,931 | 71% | Not verified | — |
| Elect Director: LeAnne M. Zumwalt | 97,926,409 | -- | -- | 45,426,491 | 48,297,931 | 68% | Not verified | — |
| 2. An amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to (i) increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and (ii) increase the number of authorized shares of common stock, par val | 102,504,108 | 88,853,129 | 293,594 | -- | -- | 53.6% | Approved | — |
| 3. The Company's stockholders' approved, on a non-binding advisory basis, the compensation of the Company's named executive officers | 89,838,833 | 51,140,010 | 2,374,057 | -- | 48,297,931 | 64% | Not verified | — |
| 4. The Company's stockholders recommended, on a non-binding advisory basis, that future advisory votes on the compensation of the Company's named executive officers be held every year | 112,927,161 | -- | 7,080,470 | -- | -- | — | Not verified | — |
| 5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 173,306,165 | 15,754,273 | 2,590,393 | -- | -- | 92% | Approved | — |
Source: Akebia Therapeutics, Inc., Form 8-K, filed with the SEC on June 22, 2026 — read the filing on EDGAR.
Each item below shows how the 142 asset managers that disclosed a Akebia Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Akebia Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Adrian Adams
Akebia Therapeutics, Inc.’s own tally for this item (“Elect Director: Adrian Adams”): 102,040,314 for, 41,312,586 withheld, per its Form 8-K filed June 22, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 34,567,571 for, 169,444 withheld, 29,240 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,238,551 | 0 | 172 | 37,046 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,520,075 | 0 | 0 | 4,498 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 541,042 | 0 | 0 | 0 | For |
| Equitable | 403,161 | 0 | 0 | 0 | For |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| Virtus | 308,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 215,912 | 0 | 0 | 0 | For |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 178,188 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 152,607 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 137,434 | 0 | 0 | 0 | For |
| AQR | 131,403 | 0 | 0 | 0 | For |
| Victory Capital | 129,170 | 0 | 0 | 0 | For |
| Global X | 110,664 | 0 | 0 | 0 | For |
| Northern Trust | 108,928 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 94,683 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 93,891 | Withhold |
| John Hancock | 65,927 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 6 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: LeAnne M. Zumwalt
Akebia Therapeutics, Inc.’s own tally for this item (“Elect Director: LeAnne M. Zumwalt”): 97,926,409 for, 45,426,491 withheld, per its Form 8-K filed June 22, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 32,166,395 for, 2,490,665 withheld, 109,195 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,238,533 | 0 | 190 | 37,046 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,515,999 | 0 | 0 | 8,574 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 541,042 | 0 | 0 | 0 | For |
| Equitable | 242,891 | 0 | 0 | 160,270 | Mixed |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 338,539 | Withhold |
| Virtus | 0 | 0 | 0 | 308,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 215,912 | Withhold |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 178,188 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 152,607 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 137,434 | Withhold |
| AQR | 0 | 0 | 0 | 131,403 | Withhold |
| Victory Capital | 0 | 0 | 0 | 129,170 | Withhold |
| Global X | 0 | 0 | 0 | 110,664 | Withhold |
| Northern Trust | 0 | 0 | 0 | 108,928 | Withhold |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 94,683 | Withhold |
| Dimensional | 0 | 0 | 0 | 93,891 | Withhold |
| John Hancock | 0 | 0 | 65,927 | 0 | Abstain |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 5 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Michael Rogers
Akebia Therapeutics, Inc.’s own tally for this item (“Elect Director: Michael Rogers”): 102,377,117 for, 40,975,783 withheld, per its Form 8-K filed June 22, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 34,600,700 for, 136,315 withheld, 29,240 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,250,793 | 0 | 172 | 24,804 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,520,075 | 0 | 0 | 4,498 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 541,042 | 0 | 0 | 0 | For |
| Equitable | 403,161 | 0 | 0 | 0 | For |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| Virtus | 308,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 215,912 | 0 | 0 | 0 | For |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 178,188 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 152,607 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 137,434 | 0 | 0 | 0 | For |
| AQR | 131,403 | 0 | 0 | 0 | For |
| Victory Capital | 129,170 | 0 | 0 | 0 | For |
| Global X | 110,664 | 0 | 0 | 0 | For |
| Northern Trust | 108,928 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 94,683 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 93,891 | Withhold |
| John Hancock | 65,927 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 2 wordings of this item as funds reported it.
53.6% Approved · of votes cast
Description as filed by funds: APPROVAL OF AN AMENDMENT TO THE COMPANY'S NINTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF CAPITAL STOCK FROM 375,000,000 TO 525,000,000 AND TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 350,000,000 TO 500,000,000.
Akebia Therapeutics, Inc.’s own tally for this item (“2. An amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to (i) increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and (ii) increase the number of au”): 102,504,108 for, 88,853,129 against — passed, per its Form 8-K filed June 22, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders approved an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to (i) increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and (ii) increase the number of authorized shares of common stock, p…”
Support: 53.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 34,766,003 for, 252 against, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,275,517 | 252 | 1 | 0 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,524,573 | 0 | 0 | 0 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 541,042 | 0 | 0 | 0 | For |
| Equitable | 403,161 | 0 | 0 | 0 | For |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| Virtus | 308,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 215,912 | 0 | 0 | 0 | For |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 178,188 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 152,607 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 137,434 | 0 | 0 | 0 | For |
| AQR | 131,403 | 0 | 0 | 0 | For |
| Victory Capital | 129,170 | 0 | 0 | 0 | For |
| Global X | 110,664 | 0 | 0 | 0 | For |
| Northern Trust | 108,928 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 94,683 | 0 | 0 | 0 | For |
| Dimensional | 93,891 | 0 | 0 | 0 | For |
| John Hancock | 65,927 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 4 wordings of this item as funds reported it.
64% Majority: yes · of votes cast
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE COMPANY'S PROXY STATEMENT.
Akebia Therapeutics, Inc.’s own tally for this item (“3. The Company's stockholders' approved, on a non-binding advisory basis, the compensation of the Company's named executive officers”): 89,838,833 for, 51,140,010 against, per its Form 8-K filed June 22, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 64% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,275,547 | 211 | 11 | 0 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,524,573 | 0 | 0 | 0 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 0 | 541,042 | 0 | 0 | Against |
| Equitable | 403,161 | 0 | 0 | 0 | For |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| Virtus | 308,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 215,912 | 0 | 0 | 0 | For |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 178,188 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 152,607 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 137,434 | 0 | 0 | 0 | For |
| AQR | 131,403 | 0 | 0 | 0 | For |
| Victory Capital | 129,170 | 0 | 0 | 0 | For |
| Global X | 110,664 | 0 | 0 | 0 | For |
| Northern Trust | 108,928 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| Dimensional | 93,891 | 0 | 0 | 0 | For |
| John Hancock | 65,927 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 55,722 | 0 | 0 | 0 | For |
Fund voting reports, all 47 managers: 34,108,977 for, 562,397 against, 11 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 6,498,984 | 3,825 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,491,066 | 0 | 0 | 0 | For |
| State Street | 4,380,084 | 4,289 | 0 | 0 | For |
| Charles Schwab | 2,018,502 | 0 | 0 | 0 | For |
| Vanguard | 1,882,037 | 0 | 0 | 0 | For |
| Fidelity | 1,361,676 | 0 | 0 | 0 | For |
| Northern Trust | 1,160,191 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 802,949 | 0 | 0 | 0 | For |
| Voleon Capital Management LP | 758,934 | 0 | 0 | 0 | For |
| Invesco | 0 | 691,172 | 0 | 0 | Against |
| Nuveen | 596,599 | 0 | 0 | 0 | For |
| AQR | 576,422 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 531,323 | 0 | 0 | 0 | For |
| Wellington | 493,974 | 0 | 0 | 0 | For |
| T. Rowe Price | 433,977 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 287,500 | 0 | 0 | 0 | For |
| Two Sigma | 249,139 | 0 | 0 | 0 | For |
| AllianceBernstein | 238,930 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 214,638 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 212,173 | 0 | 0 | 0 | For |
| SAPIENT CAPITAL LLC | 200,000 | 0 | 0 | 0 | For |
| Round Rock Advisors LLC | 165,407 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 152,607 | 0 | 0 | 0 | For |
| State of Alaska, Department of Revenue | 146,078 | 0 | 0 | 0 | For |
Institutional-manager reports, all 110 managers: 31,731,624 for, 808,649 against, 47,990 1 year. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 34 | 0 | Abstain |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Virtus | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 47 managers: 51,695 for, 34 abstained, 34,484,471 1 year, 134,596 3 year, 588 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Voleon Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 0 | 0 | 0 | -- |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 0 | 0 | 0 | -- |
| SAPIENT CAPITAL LLC | 0 | 0 | 0 | 0 | -- |
| Round Rock Advisors LLC | 0 | 0 | 0 | 0 | -- |
| Rafferty Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| State of Alaska, Department of Revenue | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 110 managers: 47,990 for, 32,393,770 1 year, 146,478 3 year, 25 2 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Akebia Therapeutics, Inc.’s own tally for this item (“5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 173,306,165 for, 15,754,273 against — passed, per its Form 8-K filed June 22, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5: The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 34,766,064 for, 185 against, 7 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,275,718 | 44 | 7 | 0 | For |
| Fidelity | 6,899,797 | 0 | 0 | 0 | For |
| BlackRock | 4,256,398 | 0 | 0 | 0 | For |
| State Street | 3,524,432 | 141 | 0 | 0 | For |
| Charles Schwab | 2,018,491 | 0 | 0 | 0 | For |
| TIAA | 546,665 | 0 | 0 | 0 | For |
| Invesco | 541,042 | 0 | 0 | 0 | For |
| Equitable | 403,161 | 0 | 0 | 0 | For |
| Goldman Sachs | 343,509 | 0 | 0 | 0 | For |
| SEI | 338,539 | 0 | 0 | 0 | For |
| Virtus | 308,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 215,912 | 0 | 0 | 0 | For |
| Lincoln Financial | 183,000 | 0 | 0 | 0 | For |
| ProShares | 178,188 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 152,607 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 137,434 | 0 | 0 | 0 | For |
| AQR | 131,403 | 0 | 0 | 0 | For |
| Victory Capital | 129,170 | 0 | 0 | 0 | For |
| Global X | 110,664 | 0 | 0 | 0 | For |
| Northern Trust | 108,928 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 107,348 | 0 | 0 | 0 | For |
| Pacific Life | 99,397 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 94,683 | 0 | 0 | 0 | For |
| Dimensional | 93,891 | 0 | 0 | 0 | For |
| John Hancock | 65,927 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 268,258,243 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.95% |
| 2 | Fidelity | 2.57% |
| 3 | BlackRock | 1.59% |
| 4 | State Street | 1.31% |
| 5 | Charles Schwab | 0.75% |
| 6 | TIAA | 0.20% |
| 7 | Invesco | 0.20% |
| 8 | Equitable | 0.15% |
| 9 | Goldman Sachs | 0.13% |
| 10 | SEI | 0.13% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.42% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 2.42% |
| 3 | State Street | 1.63% |
| 4 | Charles Schwab | 0.75% |
| 5 | Vanguard | 0.70% |
| 6 | Fidelity | 0.51% |
| 7 | Northern Trust | 0.43% |
| 8 | MELLON INVESTMENTS Corp | 0.30% |
| 9 | Voleon Capital Management LP | 0.28% |
| 10 | Invesco | 0.26% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 6.97% | 13F |
| Vanguard Group | 5.97% | 13F |
| State Street | 4.33% | 13F |
| John P. Butler | 2.42% | DEF14A |
| Geode Capital | 2.41% | 13F |
| Goldman Sachs | 1.34% | 13F |
| Millennium Management | 0.89% | 13F |
| Charles Schwab | 0.75% | 13F |
| Steven K. Burke, M.D. | 0.73% | DEF14A |
| Northern Trust | 0.73% | 13F |
Percentages above are of 268,258,243 shares outstanding, as reported by Akebia Therapeutics, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Akebia Therapeutics, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Akebia Therapeutics, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 142 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,293 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — FOR was 64% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Akebia Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 22, 2026.
Akebia Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.